Table of Contents
What happens to UPL?
UPL Closure of Trading Window The closure is in connection with the finalization of unaudited standalone and consolidated financial results of the Company for the quarter and half year ending 30th September, 2021.
Who owns UPL?
United Phosphorus Ltd
UPL/Parent organizations
Is UPL a government Company?
United Phosphorus Limited was established on 29 May 1969. The company changed its name to UPL Limited in October 2013….UPL (company)
| United Phosphorus Ltd official logo | |
|---|---|
| Formerly | United Phosphorus Limited (1969–2013) |
| Type | Public |
| Traded as | BSE: 512070 NSE: UPL NSE NIFTY 50 Constituent |
| ISIN | INE628A01036 |
Is UPL a good stock?
The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹389.5b (up 8.9% from FY 2020). Net income: ₹28.7b (up 62% from FY 2020). Profit margin: 7.4% (up from 5.0% in FY 2020).
What is the business of UPL company?
UPL Limited is a global generic crop protection chemicals and seeds company. The company is engaged in the business of agrochemicals industrial chemicals and chemical intermediates. They operate in three segments: agro chemical industrial chemicals and others.
Who is the CEO of UPL?
Jai Shroff
Jai Shroff is the Global CEO of UPL Limited. He is a well-recognized global leader in the Chemical & Agri-Inputs industry with over 30 years experience in India and internationally.
What UPL makes?
UPL Ltd. United Phosphorous (UPL) is a producer of crop protection products, intermediates, specialty chemicals and other industrial chemicals, was incorporated in the year 1969. UPL is largest producer of agrochemicals in India . It is amongst the top five post–patent agrochemical manufacturers in the world.
What is the target of UPL?
UPL Ltd., incorporated in the year 1985, is a Large Cap company (having a market cap of Rs 56554.64 Crore) operating in Pesticides/Agro Chemicals sector. ICICI Securities has add call on UPL with a target price of Rs 800. The current market price of UPL Ltd. is Rs 704.95.
What is the intrinsic value of UPL?
UPL Limited
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 30 Sep 2021 | Rs. 1,186.92 | Rs. 707.70 |
| 18 Nov 2021 | —- | Rs. 741.45 |
| -14.15 -1.91% |
What products does UPL make?
UPL Global
- Crop Protection. Herbicide. Fungicide. Insecticide. Seed Treatment.
- Crop Care. Water Conservation. Bio Solutions. Adjuvants. Plant Growth Regulator. Micronutrients And Foliar Fertilizers.
- Decco.
- Fumigants.
- Public Health.
What does UPL company do?
United Phosphorous (UPL) is a producer of crop protection products, intermediates, specialty chemicals and other industrial chemicals, was incorporated in the year 1969. UPL is largest producer of agrochemicals in India . It is amongst the top five post–patent agrochemical manufacturers in the world.
When do UPL demonstrations need to be submitted?
Here is a summary of the UPL Methodology (PDF, 282.53 KB) outlining how the formulas are applied to the UPL templates. UPL demonstrations must be submitted by the state within each state fiscal year for the services below: Intermediate Care Facility for Individuals with Intellectual Disabilities UPL Guidance (PDF, 913.86 KB)
What is the UPL demonstration for Medicaid director letter?
State Medicaid Director Letter (SMDL) 13-003 (PDF, 98.55 KB) requires states to annually submit Upper Payment Limit (UPL) demonstrations. To assist states in meeting this requirement, the Centers for Medicare & Medicaid Services (CMS) created reporting templates.
Do you need secretarial clearance for a UPL demonstration?
The Paperwork Reduction Act (PRA) process followed by CMS to receive OMB approval of the UPL templates required Secretarial clearance. This clearance, in conjunction with these regulations, require states to submit their UPL demonstrations using the templates.
Why are UPL templates important to the Medicaid program?
The UPL templates ensure states are demonstrating UPLs in a uniform manner. Standardization of UPL reporting will promote faster processing of UPL demonstrations by CMS and enhance Federal/State fiscal oversight of the Medicaid program.